Evidence map›Paper›PMID 35497310›Full record

ArticleRSC advances2021

Spatial distribution of isobaric androgens in target tissues using chemical derivatization and MALDI-2 on a trapped ion mobility quadrupole time-of-flight instrument.

C L Logan Mackay, Jens Soltwisch, Bram Heijs, Karl W Smith, Faye L Cruickshank, Annika Nyhuis, Klaus Dreisewerd, Diego Cobice

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mass Spectrometry Imaging of Cholesterol and Oxysterols.Advances in experimental medicine and biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

C L Logan MackaySIRCAMS, EastChem School of Chemistry, University of Edinburgh Scotland UK.ORCID https://orcid.org/0000-0003-1018-8353
Jens SoltwischInstitute of Hygiene, University of Münster Münster Germany.ORCID https://orcid.org/0000-0002-0258-1561
Bram HeijsMass Spectrometry Imaging Group, Leids Universitair Medisch Centrum Leiden The Netherlands.ORCID https://orcid.org/0000-0001-6328-9305
Karl W SmithMass Spectrometry Centre, Biomedical Science Research Institute (BMSRI), Ulster University Coleraine Northern Ireland UK d.cobice@ulster.ac.uk +44 (0)2892 604456.ORCID https://orcid.org/0000-0001-8551-9837
Faye L CruickshankSIRCAMS, EastChem School of Chemistry, University of Edinburgh Scotland UK.ORCID https://orcid.org/0000-0002-9582-5149
Annika NyhuisBruker Daltonics GmbH & Co. KG Bremen Germany.
Klaus DreisewerdInstitute of Hygiene, University of Münster Münster Germany.ORCID https://orcid.org/0000-0002-7619-808X
Diego CobiceMass Spectrometry Centre, Biomedical Science Research Institute (BMSRI), Ulster University Coleraine Northern Ireland UK d.cobice@ulster.ac.uk +44 (0)2892 604456.ORCID https://orcid.org/0000-0001-5283-2931
University of Edinburgh · GBUniversity of Münster · DEUniversity of Ulster · GBBruker (Germany) · DELeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is initially treated

Identifiers

PMID35497310
PMCPMC9042386
OpenAlexW3205030784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.